Yamano Hiroaki, Yamazaki Tsutomu, Sato Kozue, Shiga Sadashi, Hagiwara Toshikatsu, Ouchi Kazunobu, Kishimoto Toshio
Department of Virology 1, National Institute of Infectious Diseases, 1-23-1 Toyama, Shinjuku, Tokyo, Japan 162-8640.
Antimicrob Agents Chemother. 2005 Jun;49(6):2519-21. doi: 10.1128/AAC.49.6.2519-2521.2005.
The inhibitory effects of hinokitiol (beta-thujaplicin) on Chlamydia trachomatis D/UW-3/Cx were shown by MIC, minimum lethal concentration (MLC), and preinoculation minimal microbicidal concentration assays using HeLa 229 cells. The MIC and the MLC were both 32 microg/ml. Further evaluation of hinokitiol as a topical agent against C. trachomatis is warranted.
通过使用HeLa 229细胞的最小抑菌浓度(MIC)、最小致死浓度(MLC)和接种前最小杀菌浓度试验,显示了扁柏酚(β-崖柏素)对沙眼衣原体D/UW-3/Cx的抑制作用。MIC和MLC均为32μg/ml。有必要进一步评估扁柏酚作为抗沙眼衣原体局部用药的效果。